These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 843647)

  • 61. Macrophage defences against respiratory tract infections.
    Gordon SB; Read RC
    Br Med Bull; 2002; 61():45-61. PubMed ID: 11997298
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The principles of defense of the respiratory mucous membrane against infections (author's transl)].
    Naumann HH
    HNO; 1978 Dec; 26(12):397-405. PubMed ID: 363664
    [No Abstract]   [Full Text] [Related]  

  • 63. The role of the respiratory burst of phagocytes in host defense.
    Shepherd VL
    Semin Respir Infect; 1986 Jun; 1(2):99-106. PubMed ID: 2825313
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanisms of host defense against respiratory infection.
    Gaunt PN; Seal DV
    Int Anesthesiol Clin; 1984; 22(4):113-29. PubMed ID: 6392113
    [No Abstract]   [Full Text] [Related]  

  • 65. [Peritonitis and defense against infection].
    Feifel G; Gaitzsch A
    Chirurg; 1983 May; 54(5):293-8. PubMed ID: 6347552
    [No Abstract]   [Full Text] [Related]  

  • 66. Defense mechanisms of the lungs.
    Cohen AB; Gold WM
    Annu Rev Physiol; 1975; 37():325-50. PubMed ID: 1092251
    [No Abstract]   [Full Text] [Related]  

  • 67. Lung defense against infection.
    Quie PG
    J Pediatr; 1986 May; 108(5 Pt 2):813-6. PubMed ID: 3701533
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens.
    Rosenberger CM; Finlay BB
    Nat Rev Mol Cell Biol; 2003 May; 4(5):385-96. PubMed ID: 12728272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML; Arêas AP; Ho PL
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Unusual features of infections in the aging.
    Finkelstein MS
    Geriatrics; 1982 Apr; 37(4):65-7, 71-5, 78. PubMed ID: 7060948
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Cellular antibacterial immunity (author's transl)].
    Hahn H
    Infection; 1979; 7 Suppl 6():593-6. PubMed ID: 551085
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Factors of resistance to infection and cirrhosis].
    Vildé JL; Bricaire F
    Med Chir Dig; 1979; 8(1):53-5. PubMed ID: 470482
    [No Abstract]   [Full Text] [Related]  

  • 73. The effect of pulmonary edema on antibacterial defenses of the lung.
    LaForce FM; Mullane JF; Boehme RF; Kelly WJ; Huber GL
    J Lab Clin Med; 1973 Oct; 82(4):634-48. PubMed ID: 4755437
    [No Abstract]   [Full Text] [Related]  

  • 74. Pulmonary host defense mechanisms.
    Harada RN; Repine JE
    Chest; 1985 Feb; 87(2):247-52. PubMed ID: 3881229
    [No Abstract]   [Full Text] [Related]  

  • 75. Pulmonary surfactant and respiratory infections.
    Bisetti A
    Respiration; 1989; 55 Suppl 1():45-8. PubMed ID: 2682868
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An overview of pulmonary host defense.
    DeLong PA; Kotloff RM
    Semin Roentgenol; 2000 Apr; 35(2):118-23. PubMed ID: 10812649
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Symposium on the chemotherapy of bacterial infections. (2) Points at issue in the chemotherapy of bacterial infection in the field of internal medicine. v) Infection and chemotherapy in the host with lowered-resistance (author's transl)].
    Tsubura E
    Nihon Naika Gakkai Zasshi; 1977 Oct; 66(10):1394-9. PubMed ID: 591746
    [No Abstract]   [Full Text] [Related]  

  • 78. [Airway biofilm disease and autoimmunity].
    Kobayashi O
    Nihon Naika Gakkai Zasshi; 2001 Dec; 90(12):2438-42. PubMed ID: 11917869
    [No Abstract]   [Full Text] [Related]  

  • 79. Target the Host, Kill the Bug; Targeting Host Respiratory Immunosuppressive Responses as a Novel Strategy to Improve Bacterial Clearance During Lung Infection.
    Kelly AM; McLoughlin RM
    Front Immunol; 2020; 11():767. PubMed ID: 32425944
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Immune mechanism in respiratory tract infections].
    Protivinsky R
    Hippokrates; 1975 Aug; 46(3):374-84. PubMed ID: 770401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.